Incidental Mutation 'R5714:Bcar3'
ID 451036
Institutional Source Beutler Lab
Gene Symbol Bcar3
Ensembl Gene ENSMUSG00000028121
Gene Name breast cancer anti-estrogen resistance 3
Synonyms AND-34
MMRRC Submission 043186-MU
Accession Numbers
Essential gene? Possibly essential (E-score: 0.561) question?
Stock # R5714 (G1)
Quality Score 225
Status Not validated
Chromosome 3
Chromosomal Location 122213406-122323840 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) G to A at 122248736 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Valine to Methionine at position 112 (V112M)
Ref Sequence ENSEMBL: ENSMUSP00000029766 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000029766]
AlphaFold Q9QZK2
Predicted Effect possibly damaging
Transcript: ENSMUST00000029766
AA Change: V112M

PolyPhen 2 Score 0.882 (Sensitivity: 0.82; Specificity: 0.94)
SMART Domains Protein: ENSMUSP00000029766
Gene: ENSMUSG00000028121
AA Change: V112M

DomainStartEndE-ValueType
low complexity region 126 145 N/A INTRINSIC
SH2 146 234 3.17e-21 SMART
low complexity region 395 406 N/A INTRINSIC
RasGEF 539 814 2.55e-52 SMART
Predicted Effect noncoding transcript
Transcript: ENSMUST00000197198
Predicted Effect noncoding transcript
Transcript: ENSMUST00000197590
Coding Region Coverage
  • 1x: 99.3%
  • 3x: 98.7%
  • 10x: 97.3%
  • 20x: 95.5%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estrogen resistant. Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance. The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
PHENOTYPE: Mice homozygous for a knock-out allele exhibit cataracts due to rupture of the lens capsule and liquefaction of lens cortical fibers. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 46 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Alpk2 G T 18: 65,438,532 (GRCm39) Q1421K possibly damaging Het
Ankub1 G A 3: 57,580,258 (GRCm39) T133M probably benign Het
Cacna1s A G 1: 136,039,804 (GRCm39) K1476R probably benign Het
Cdc42ep1 C A 15: 78,733,977 (GRCm39) A359E possibly damaging Het
Cemip T A 7: 83,624,387 (GRCm39) D483V probably damaging Het
Cyp4f39 G A 17: 32,700,799 (GRCm39) R156H probably damaging Het
Dpys T A 15: 39,720,553 (GRCm39) H69L probably damaging Het
Fbxl21 A G 13: 56,674,885 (GRCm39) I79V probably benign Het
Fgf9 T C 14: 58,347,022 (GRCm39) L205P probably damaging Het
Fkbp14 A G 6: 54,562,835 (GRCm39) F144L probably damaging Het
Flnb A C 14: 7,929,073 (GRCm38) D1934A probably damaging Het
Garre1 G A 7: 33,939,941 (GRCm39) Q717* probably null Het
Glul T C 1: 153,782,243 (GRCm39) probably benign Het
Helz T A 11: 107,517,347 (GRCm39) probably null Het
Kap A G 6: 133,828,956 (GRCm39) Y42H probably benign Het
Kcnh8 T C 17: 53,285,150 (GRCm39) V1040A probably benign Het
Kptn A G 7: 15,854,683 (GRCm39) probably null Het
Lypd3 A G 7: 24,338,494 (GRCm39) T182A possibly damaging Het
Mcm5 A C 8: 75,847,538 (GRCm39) D445A probably damaging Het
Mios T A 6: 8,215,434 (GRCm39) I210K probably damaging Het
Nat8f2 A G 6: 85,844,891 (GRCm39) V157A probably benign Het
Or1e16 T A 11: 73,286,187 (GRCm39) probably null Het
Pard3b C A 1: 62,677,075 (GRCm39) A1140E probably null Het
Pcnt A T 10: 76,256,325 (GRCm39) D638E probably damaging Het
Pdgfra T C 5: 75,346,673 (GRCm39) I834T probably damaging Het
Phyhd1 T A 2: 30,169,994 (GRCm39) L162H probably damaging Het
Polg C A 7: 79,101,739 (GRCm39) A1026S possibly damaging Het
Prl7c1 A T 13: 27,962,949 (GRCm39) L18* probably null Het
Rars2 T A 4: 34,645,779 (GRCm39) M232K probably benign Het
Rtl1 A G 12: 109,560,114 (GRCm39) V575A probably damaging Het
Slc18b1 A T 10: 23,674,664 (GRCm39) T40S probably benign Het
Slc22a19 T C 19: 7,688,387 (GRCm39) T58A probably damaging Het
Slc27a6 A T 18: 58,731,625 (GRCm39) E325V probably damaging Het
Slc35e2 C T 4: 155,694,483 (GRCm39) P10L probably benign Het
Srd5a3 T A 5: 76,301,413 (GRCm39) F214Y probably benign Het
Tgfbr2 A T 9: 116,004,092 (GRCm39) L5Q probably damaging Het
Tmem94 C A 11: 115,684,016 (GRCm39) Q779K probably benign Het
Ttn G A 2: 76,652,837 (GRCm39) P216S probably benign Het
Ush2a A T 1: 188,132,454 (GRCm39) Q892L probably benign Het
Vgll4 A T 6: 114,867,737 (GRCm39) M38K possibly damaging Het
Vmn2r109 A G 17: 20,773,121 (GRCm39) I500T probably damaging Het
Vps33a T C 5: 123,707,563 (GRCm39) I135V probably benign Het
Wscd1 T C 11: 71,675,261 (GRCm39) probably null Het
Zfp457 C A 13: 67,444,490 (GRCm39) M4I possibly damaging Het
Zfp532 G A 18: 65,756,606 (GRCm39) G180R possibly damaging Het
Zfp97 A G 17: 17,365,871 (GRCm39) T457A possibly damaging Het
Other mutations in Bcar3
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00662:Bcar3 APN 3 122,306,585 (GRCm39) missense probably benign 0.36
IGL01372:Bcar3 APN 3 122,316,943 (GRCm39) missense probably damaging 1.00
IGL02681:Bcar3 APN 3 122,306,417 (GRCm39) splice site probably null
IGL03403:Bcar3 APN 3 122,306,618 (GRCm39) missense probably benign 0.01
R0408:Bcar3 UTSW 3 122,302,033 (GRCm39) missense probably damaging 0.98
R0531:Bcar3 UTSW 3 122,220,148 (GRCm39) missense probably benign 0.00
R0798:Bcar3 UTSW 3 122,318,948 (GRCm39) missense probably benign 0.01
R1445:Bcar3 UTSW 3 122,316,840 (GRCm39) missense probably damaging 0.98
R1892:Bcar3 UTSW 3 122,301,785 (GRCm39) missense probably benign 0.00
R2138:Bcar3 UTSW 3 122,306,645 (GRCm39) missense probably damaging 1.00
R3236:Bcar3 UTSW 3 122,318,645 (GRCm39) missense probably benign 0.02
R3237:Bcar3 UTSW 3 122,318,645 (GRCm39) missense probably benign 0.02
R3832:Bcar3 UTSW 3 122,220,298 (GRCm39) missense probably damaging 1.00
R4801:Bcar3 UTSW 3 122,323,243 (GRCm39) missense probably benign 0.22
R4802:Bcar3 UTSW 3 122,323,243 (GRCm39) missense probably benign 0.22
R5342:Bcar3 UTSW 3 122,220,298 (GRCm39) missense probably damaging 1.00
R5364:Bcar3 UTSW 3 122,323,281 (GRCm39) missense probably benign 0.41
R5560:Bcar3 UTSW 3 122,220,224 (GRCm39) missense possibly damaging 0.92
R5716:Bcar3 UTSW 3 122,306,564 (GRCm39) missense probably damaging 1.00
R5944:Bcar3 UTSW 3 122,316,932 (GRCm39) missense probably benign
R6478:Bcar3 UTSW 3 122,220,225 (GRCm39) missense probably benign 0.04
R6615:Bcar3 UTSW 3 122,220,282 (GRCm39) missense probably benign 0.00
R6996:Bcar3 UTSW 3 122,302,033 (GRCm39) missense possibly damaging 0.95
R7272:Bcar3 UTSW 3 122,302,045 (GRCm39) missense possibly damaging 0.92
R7308:Bcar3 UTSW 3 122,302,142 (GRCm39) missense probably benign 0.00
R7353:Bcar3 UTSW 3 122,306,341 (GRCm39) missense probably benign 0.00
R7465:Bcar3 UTSW 3 122,316,879 (GRCm39) missense probably benign 0.13
R7816:Bcar3 UTSW 3 122,220,343 (GRCm39) missense probably benign 0.00
R7899:Bcar3 UTSW 3 122,301,902 (GRCm39) missense probably damaging 0.97
R8066:Bcar3 UTSW 3 122,318,573 (GRCm39) missense probably damaging 1.00
R8165:Bcar3 UTSW 3 122,304,805 (GRCm39) unclassified probably benign
R8285:Bcar3 UTSW 3 122,306,383 (GRCm39) missense probably benign 0.00
R9224:Bcar3 UTSW 3 122,319,091 (GRCm39) missense probably damaging 1.00
R9340:Bcar3 UTSW 3 122,298,462 (GRCm39) start gained probably benign
R9480:Bcar3 UTSW 3 122,277,618 (GRCm39) nonsense probably null
R9631:Bcar3 UTSW 3 122,301,801 (GRCm39) missense possibly damaging 0.91
Z1177:Bcar3 UTSW 3 122,298,667 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- TGAGAAGGATCTGGCTTCGTTC -3'
(R):5'- GACTTTAACAGGATCATTCGAGAC -3'

Sequencing Primer
(F):5'- ACCTGCCTTTGGGTATACTGTCTG -3'
(R):5'- GGATCATTCGAGACCTTTACCAAG -3'
Posted On 2017-01-03